Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi MDAX UCITS ETF Dist

MD4X · FR0011857234 · class Dist · EUR · domicile France
Equity · Germany · Mid capSFDR art. 6
Index tracked: MDAX Net Return
TER
0.20%+ trans. 0.01%
Fund size
193 m EUR
Tracking difference
−0.47%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Mixed (acc. and/or dist.)
Launch 15 May 2014 · costs from the KID as of 2 Sept 2026 · 52 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Sub-fund is a passively managed index-based UCITS. The Fund's objective is to replicate, both upwards and downwards, the performance of the MDAX Net Return Index (net dividends reinvested) (the "Benchmark"), representative of mid-cap German companies, while minimising the tracking error between the Fund's performance and that of the Benchmark. The expected level of the Tracking Error under normal market conditions is indicated in the Fund prospectus. The Deutsche Börse AG website (www.dax-indices.com) provides more detailed information about the…

Performance since series start (in euro) — base 100

15 May 20148 Sept 2026 · dividends reinvested where declared by the issuer
20152017201920212023202521590189
High 215 (30 Aug 2021) · low 90 (15 Oct 2014) · last 189. Past performance is not indicative of future results.

Returns in euro

1 year+7.8%
3 years+18.6%
5 years−11.9%
10 years+43.7%
Since series start+89.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)18.45%17.86%19.50%
Max drawdown−14.46%−18.68%−40.49%
Sharpe0.210.11-0.22
Sortino0.310.16-0.30
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · MD4X · FR00118572341
RebalixMD4X · FR0011857234 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
YearFundIndexTD
2025+18.76%+19.65%−0.89%
2024−6.03%−5.71%−0.33%
2023+7.86%+8.04%−0.18%
2022−28.62%−28.49%−0.13%
2021+13.83%+14.05%−0.22%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 52 securities · top-10 weight = 38.0%
Top holdingsWeight
TALANX AG4.7%
DEUTSCHE LUFTHANSA NOMINATIVE4.6%
THYSSEN KRUPP AG4.4%
KNORR-BREME AG4.3%
DELIVERY HERO4.1%
SARTORIUS PFD3.9%
HENSOLDT AG3.1%
DR ING HC F PORSCHE AG3.1%
EVONIK INDUSTRIES AG2.9%
NORDEX SE2.9%
Countries (% of fund)
Germany100.0%
Sectors (% of fund)
Industrials29.5%Consumer Discretionary19.1%Materials16.4%Information Technology11.9%Financials8.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
MD4X · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
MDX · Euronext Paris
+ 20 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0011857234/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0011857234/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0011857234/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0011857234
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · MD4X · FR00118572342